Spot Trading’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$213K Buy
+2,100
New +$225K ﹤0.01% 2193
2017
Q2
Sell
-8,500
Closed -$1.03M 3565
2017
Q1
$1.03M Sell
8,500
-43,100
-84% -$5.29M 0.03% 729
2016
Q4
$5.77M Buy
51,600
+21,600
+72% +$2.6M 0.14% 177
2016
Q3
$3.98M Buy
30,000
+8,600
+40% +$822K 0.08% 339
2016
Q2
$1.96M Buy
+21,400
New +$1.8M 0.03% 696
2016
Q1
Sell
-400
Closed -$28K 4182
2015
Q4
$28K Sell
400
-200
-33% -$16.3K ﹤0.01% 3174
2015
Q3
$55K Buy
+600
New +$66.7K ﹤0.01% 3262
2014
Q4
Sell
-100
Closed -$8K 4541
2014
Q3
$8K Buy
+100
New +$8.85K ﹤0.01% 4087

Other funds holding GWPH

Spot Trading's GWPH Position: Q3 2017 in Review

Spot Trading opened a new position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2017: 1,350 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #2428 among its holdings. This is a return to the name: Spot Trading previously reported a position in GWPH as recently as Q1 2017.

Spot Trading first reported a position in GWPH in Q2 2016 and has held it in 4 quarters since. The position peaked at $1.05M in Q2 2016. 181 funds tracked by Wall St. Rank hold GWPH as of Q3 2017.

  • Spot Trading held 1,350 shares of GW Pharmaceuticals Plc American Depositary Shares worth $137K as of Q3 2017.
  • GW Pharmaceuticals Plc American Depositary Shares was a new Spot Trading position in Q3 2017.
  • GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2428 holding.
  • Spot Trading first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and has held it in 4 quarters since.
  • Spot Trading's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.05M in Q2 2016.
  • 181 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.